💥 Gate Square Event: #PTB Creative Contest# 💥
Post original content related to PTB, CandyDrop #77, or Launchpool on Gate Square for a chance to share 5,000 PTB rewards!
CandyDrop x PTB 👉 https://www.gate.com/zh/announcements/article/46922
PTB Launchpool is live 👉 https://www.gate.com/zh/announcements/article/46934
📅 Event Period: Sep 10, 2025 04:00 UTC – Sep 14, 2025 16:00 UTC
📌 How to Participate:
Post original content related to PTB, CandyDrop, or Launchpool
Minimum 80 words
Add hashtag: #PTB Creative Contest#
Include CandyDrop or Launchpool participation screenshot
🏆 Rewards:
🥇 1st
Pfizer, Bristol-Myers Squibb, and Roche are advancing cancer therapies focusing on EMT, with Pfizer's PF-06952229 and BMS-986416 targeting TGF-β to inhibit metastasis. Propanc Biopharma's PRP is a dual-action proenzyme therapy that can reverse EMT and eliminate cancer stem cells, showing an extension of survival by 3.4 months in compassionate use studies. PRP holds 90 patents and plans to initiate Phase I clinical trials in 2026 aimed at preventing the recurrence and resistance of various cancers.